688298.SS
Price:
$23.34
Market Cap:
$4.51B
Zhejiang Orient Gene Biotech Co., Ltd. researches and develops, produces, and sells colloidal gold tests, urinalysis strips, raw materials, instruments, and molecular diagnosis products primarily in China. Its products include genetic diagnosis products; colloidal gold rapid diagnostic tests for drugs of abuse, infectious diseases, fertility, cardiac and tumor markers, and autoimmunity; dry chemical strips; bio-liquid diagnostic kits; clinical test instruments; POCT time-resolved fluor immunoassay test kits; raw materials; etc. The company also exports its products to North and South America, Europe, South Asia, Southeast Asia, the Middle East, Africa, Russia, and Australia. Zhejiang Orient ...[Read more]
Industry
Medical - Devices
IPO Date
2020-02-05
Stock Exchange
SHH
Ticker
688298.SS
According to Zhejiang Orient Gene Biotech Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -7.97. This represents a change of -31.76% compared to the average of -11.68 of the last 4 quarters.
The mean historical PE Ratio of Zhejiang Orient Gene Biotech Co., Ltd. over the last ten years is 106.85. The current -7.97 PE Ratio has changed -845.90% with respect to the historical average. Over the past ten years (40 quarters), 688298.SS's PE Ratio was at its highest in in the March 2019 quarter at 280.65. The PE Ratio was at its lowest in in the March 2023 quarter at -61.81.
Average
106.85
Median
14.22
Minimum
-18.03
Maximum
386.90
Discovering the peaks and valleys of Zhejiang Orient Gene Biotech Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 75.96%
Maximum Annual PE Ratio = 386.90
Minimum Annual Increase = -445.40%
Minimum Annual PE Ratio = -18.03
Year | PE Ratio | Change |
---|---|---|
2024 | -10.90 | -39.53% |
2023 | -18.03 | -445.40% |
2022 | 5.22 | 30.00% |
2021 | 4.02 | -71.75% |
2020 | 14.22 | -91.14% |
2019 | 160.40 | -19.79% |
2018 | 199.97 | -48.32% |
2017 | 386.90 | 75.96% |
The current PE Ratio of Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-7.90
5-year avg
-1.10
10-year avg
106.85
Zhejiang Orient Gene Biotech Co., Ltd.’s PE Ratio is greater than Daan Gene Co., Ltd. (-15.62), less than Intco Medical Technology Co., Ltd. (9.21), greater than Beijing Hotgen Biotech Co., Ltd. (-56.29), less than Sansure Biotech Inc. (0), less than null (37.31),
Company | PE Ratio | Market cap |
---|---|---|
-15.62 | $8.24B | |
9.21 | $14.56B | |
-56.29 | $10.64B | |
0 | $11.19B | |
37.31 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zhejiang Orient Gene Biotech Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Zhejiang Orient Gene Biotech Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Zhejiang Orient Gene Biotech Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS)?
What is the highest PE Ratio for Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS)?
What is the 3-year average PE Ratio for Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS)?
What is the 5-year average PE Ratio for Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS)?
How does the current PE Ratio for Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) compare to its historical average?